Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yasemin Sezgin
Observed name:
Y. Sezgin
Institutions:
Nationwide Children's Hospital,
Abigail Wexner Research Institute
Observed institutions:
Nationwide Children's Hospital,
Abigail Wexner Research Institute
ORCID:
0009-0009-7364-5911
Observed ORCID:
0009-0009-7364-5911
OpenAlex ID:
A5019775396
CD38-CAR human NK cells in combination with ATRA enhance cytotoxicity against CD38-expressing hematologic malignancies
2024
·
Ella Troy
, Joseph Caporale
, et al.
·
Blood Neoplasia
·
15
Off-the-shelf allogeneic polyclonal CD38KO/CD38-CAR γδT cells for the treatment of T cell malignancies
2025
·
Genesis Snyder
, Alexia K. Martin
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
3
PDF
P.144 Developing Cas13-ADAR-mediated DUX4 mRNA editing as a prospective therapy for FSHD
2022
·
N. Saljoughian
, L. Rizzotto
, et al.
·
Neuromuscular Disorders
·
1
Expanded NK and fratricide-resistant CD70 CAR-NK cells are potent against patient-derived glioblastoma cells in vitro and in vivo
2026
·
Misaal Mehboob
, Matthew Rätsep
, et al.
·
Cancer Immunology Immunotherapy
Eliminating the Tigit Checkpoint Releases Cd33 Car Nk Cell Potency Against Aml
2026
·
A.R. Campbell
, M. Jennings
, et al.
·
Cytotherapy
125 Sequential CRISPR/Cas9 editing enhances generation of triple knockout porcine fibroblasts for xenotransplantation
2026
·
M. Navarro
, C. Alvarez
, et al.
·
Reproduction Fertility and Development
Show more works
View as search
Works count:
6
Citation count:
19
H-index:
2
I10-index:
1
Year
Topic
Type